Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology entities : Novo nordisk a::S save search
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
report reach therapeutics market
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.22%
H: 0.21%
C: -0.34%
vent-02 trial therapeutics results
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.04%
H: 0.19%
C: -1.52%
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.04%
H: 0.19%
C: -1.52%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-08 (Crawled : 13:30) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.62%
H: 0.5%
C: 0.36%
repurchase
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-08 (Crawled : 12:30) - biospace.com/
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.62%
H: 0.5%
C: 0.36%
conference therapeutics
REDUCED secures EUR 6 million financing led by Novo Holdings to scale its natural food ingredients business
Published: 2024-04-04 (Crawled : 06:00) - prnewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.1%
H: 0.46%
C: -2.32%
business natural million food
2023 Novo Holdings Asia Investments Annual Review/Business Update
Published: 2024-04-03 (Crawled : 07:00) - prnewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
investments update asia
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.96%
H: 1.3%
C: 1.13%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.19%
H: 0.97%
C: 0.04%
repurchase
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
Published: 2024-03-25 (Crawled : 10:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.19%
H: 0.97%
C: 0.04%
disease pipeline pharmaceuticals acquire cardiovascular
Novo Nordisk A/S - Articles of Association 2024
Published: 2024-03-25 (Crawled : 08:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.19%
H: 0.97%
C: 0.04%
association
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published: 2024-03-21 (Crawled : 16:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.04%
H: 1.6%
C: 0.64%
awiqli approval treatment diabetes insulin
Resolutions from the Annual General Meeting of Novo Nordisk A/S
Published: 2024-03-21 (Crawled : 15:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.04%
H: 1.6%
C: 0.64%
meeting
Novo Nordisk A/S - share repurchase programme
Published: 2024-03-18 (Crawled : 14:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.6%
H: 1.66%
C: 1.0%
repurchase
2023 Novo Holdings Bioindustrial Investments Team Annual Review/Business Update
Published: 2024-03-15 (Crawled : 09:00) - prnewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.52%
H: 0.09%
C: -1.13%
investments update
Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.77%
H: 0.05%
C: -0.93%
pharma company astrazeneca acquired agreement
Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published: 2024-03-13 (Crawled : 18:00) - prnewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.64%
H: 0.94%
C: -0.56%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
report distribution year global market
Novo Holdings reports Total Income and Investment Returns of DKK 31 billion (€4.2 billion) for 2023. Total Assets grow by 38% to DKK 1,114 billion (€149 billion)
Published: 2024-03-12 (Crawled : 07:00) - prnewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.27%
H: 2.67%
C: 2.67%
total
Novo Nordisk A/S - share repurchase programme
Published: 2024-03-11 (Crawled : 13:00) - globenewswire.com
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.23%
H: 0.11%
C: -1.6%
repurchase
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.